Joe Biden beats President Donald Trump in three polls released last week. What was surprising is that Biden was able to pull off the feat despite the recent resurgence in Trump’s popularity as his administration confronts the coronavirus outbreak in the U.S.
Joe Biden posted a two-point lead over Donald Trump in an ABC News/Washington Post poll. Biden got 49 percent over Trump’s 47 percent based on results released on Sunday, according to Politico.
Biden also bested Trump in a Fox News survey among registered voters. Biden raked in 49 points against Trump’s 40 percent based on the results of Fox News’ survey, which was released last week.
Biden also led by 3 points in a polled conducted by Monmouth University. The results revealed that Biden got 48 percent against Trump’s 45 percent.
According to the publication, the results of the three polls show a consistent pattern. Donald Trump has improved his approval rating but it might not translate to a vote for his second term. “The polls suggest a slightly larger-than-usual slice of Democratic-leaning and independent voters are telling pollsters they now approve of the job Trump is doing as president — but support for giving him a second term lags behind among these same voters,” Politico wrote.
Trump’s approval rating reached a new high based on recent polls. The POTUS has an average approval rating of 47 percent, the highest since he became the President, NPR reported. The figure also represents a three-point increase over the last two weeks.
A Gallup poll revealed that 60 percent of American adults approve of how Trump is handling the coronavirus pandemic. Meanwhile, 51 percent of Fox News’ respondents approved of his handling of the health crisis. Meanwhile, both Reuters/Ipsos and Economist/YouGov polls revealed that 49 percent approved of his actions.
“No, I think that we've handled it really well,” Trump said on Monday. “The American public thinks that we've handled it well if you look at polling data.”
However, an expert said that the bounce to his popularity is minimal. “We're seeing although his numbers have inched up, it's still roughly in his zone of support,” Marist College Institute for Public Opinion director Lee Miringoff said. “Look, he's not getting the rally-around-the-president [effect] that presidents in crisis have gotten.”


California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Japan Election 2026: Sanae Takaichi Poised for Landslide Win Despite Record Snowfall
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns 



